Congress Large Cap Growth ETFCAML

Congress Large Cap Growth ETF (CAML) trades on Nasdaq as a vanilla growth wrapper, but the real action is in the fee schedule, not the stocks. The fund’s mandate promises exposure to large-cap US growth equities, yet the Nasdaq listing pages reveal only a ticker, a price, and a daily volume that never breaks into the top tier of ETFs. The issuer’s marketing material is polished, but the EDGAR filings confirm the fund is a regulatory construct, not a story. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/caml; SEC EDGAR search, https://www.sec.gov/edgar/search/#/q=CAML)

What CAML actually is: a growth ETF wrapped in an expense ratio. The fund’s top holdings and concentration are disclosed in the prospectus, but the Nasdaq page doesn’t show them-because the page is just the plumbing, not the plumbing’s contents. The issuer’s pitch deck may feature sunlit campuses and CEO quotes, but the SEC filing proves the fund is built on paper, not product. The FINRA Fund Analyzer confirms the fee structure, but the only thing being analysed is how much of your money doesn’t compound. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

The fund’s prospectus outlines the tracking method and index, but the Nasdaq page doesn’t surface the underlying constituents or weights in real time. That opacity is standard for ETFs, yet it turns the wrapper into a black box wrapped in a fee. The issuer’s marketing promises growth, but the only growth visible is the expense ratio, which compounds quietly while the stocks do the real work. The SEC filing proves the fund exists within the regulatory framework, but the framework doesn’t guarantee performance. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/caml; SEC EDGAR search, https://www.sec.gov/edgar/search/#/q=CAML)

The Nasdaq page for CAML shows daily price, volume, and basic stats, but the chart route stops at the ticker-no intraday candles, no depth, just the wrapper’s daily dance. The fund’s liquidity is adequate for retail flows, but it isn’t a blockbuster. The issuer’s marketing may claim “broad growth exposure,” but the reality is a fee on a basket you can’t see. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/caml)

What changed today: nothing structural. The fund’s holdings, fee, and mandate remain unchanged; the Nasdaq page updates the price and volume like a metronome. The only new data point is the passage of another trading day. The issuer’s marketing may refresh the slides, but the fund’s substance is static. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/caml)

What remains unproven: the fund’s top holdings, concentration, and tracking error versus the index. The Nasdaq page doesn’t publish them; the SEC filing points to the prospectus, but the prospectus isn’t live on the page. The FINRA Fund Analyzer shows the fee, but not how the fund tracks its benchmark. The evidence rail does not supply the holdings, weights, or tracking deviation. (source: SEC EDGAR search, https://www.sec.gov/edgar/search/#/q=CAML; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)